A CLINICAL TRIAL ON â??IRATHAK KAARIYA KULIKAIâ?? IN THE MANAGEMENT OF â??NEERILIVUâ??(DIABETES MELLITUS)
Phase 2
- Conditions
- Health Condition 1: E11- Type 2 diabetes mellitus
- Registration Number
- CTRI/2021/01/030591
- Lead Sponsor
- Government Siddha Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Type II Diabetes mellitus, previously diagnosed diabetic patients.
Exclusion Criteria
Type I Diabetes mellitus
Gestational Diabetes mellitus
Lactating mother
Smoking / Alcohol
Have a history of frequent and/or severe allergic reactions with multiple medications.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting Blood sugar level and complaints have been reduced during treatment or after treatmentTimepoint: 1 year
- Secondary Outcome Measures
Name Time Method Find out the pre clinical study of the trail drug. <br/ ><br>Evaluate the efficacy of IRATHAK KAARIYA KULIKATimepoint: 1 year